[HTML] discoverymedicine.com

[HTML][HTML] Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer

YY Shao, CC Lin, CH Yang - Discovery Medicine, 2010 - discoverymedicine.com
Tyrosine kinase inhibitors of the epidermal growth factor receptor, gefitinib and erlotinib,
have changed the treatment paradigm of advanced non-small cell lung cancer (NSCLC) …
被引用次数：21 相关文章
[HTML] discoverymedicine.com

[HTML][HTML] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer

YY Shao, CC Lin, CH Yang - Discovery Medicine, 2010 - discoverymedicine.com
Tyrosine kinase inhibitors of the epidermal growth factor receptor, gefitinib and erlotinib,
have changed the treatment paradigm of advanced non-small cell lung cancer (NSCLC) …

Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer

YY Shao, CC Lin, CH Yang - Discovery medicine, 2010 - pubmed.ncbi.nlm.nih.gov
Tyrosine kinase inhibitors of the epidermal growth factor receptor, gefitinib and erlotinib,
have changed the treatment paradigm of advanced non-small cell lung cancer (NSCLC) …
[PDF] researchgate.net

[PDF][PDF] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer

YY Shao, CC Lin, CS Yang - Discovery Medicine, 2010 - researchgate.net
Tyrosine kinase inhibitors of the epidermal growth factor receptor, gefitinib and erlotinib,
have changed the treatment paradigm of advanced nonsmall cell lung cancer (NSCLC) …

Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer.

YY Shao, CC Lin, CH Yang - Discovery Medicine, 2010 - europepmc.org
Tyrosine kinase inhibitors of the epidermal growth factor receptor, gefitinib and erlotinib,
have changed the treatment paradigm of advanced non-small cell lung cancer (NSCLC) …